Glutathione is quantitatively the most important endogenous scavenger system. Glutathione depletion in skeletal muscle is pronounced following major trauma and sepsis in intensive care unit patients. Also, following elective surgery, glutathione depletion occurs in parallel with a progressive decline in muscle glutamine concentration. The present study was designed to test the hypothesis that glutamine supplementation may counteract glutathione depletion in a human trauma model. A homogeneous group of patients (n l 17) undergoing a standardized surgical procedure were prospectively randomly allocated to receive glutamine (0.56 g : day − 1 : kg − 1 ) or placebo as part of isonitrogenous and isocaloric nutrition. Percutaneous muscle biopsies and blood samples were taken pre-operatively and at 24 and 72 h after surgery. The concentrations of muscle glutathione and related amino acids were determined in muscle tissue and plasma. In the control (unsupplemented) subjects, total muscle glutathione had decreased by 47p8 % and 37p11 % and reduced glutathione had decreased by 53p10 % and 45p16 % respectively at 24 and 72 h after surgery (P 0.05). In contrast, in the glutaminesupplemented group, no significant post-operative decreases in total or reduced glutathione were seen following surgery. Muscle free glutamine had decreased at 72 h after surgery in both groups, by 41.4p14.8 % (P 0.05) in the glutamine-supplemented group and by 46.0p14.3 % (P 0.05) in the control group. In conclusion, the present study demonstrates that intravenous glutamine supplementation attenuates glutathione depletion in skeletal muscle in humans following standardized surgical trauma.
INTRODUCTION
Following trauma and sepsis, there is a loss of muscle protein that is related to the trauma itself as well as to physical inactivity. Protein synthesis decreases, while protein degradation is unaltered or increased [1, 2] , resulting in a net loss of muscle protein. In addition, this catabolic state is characterized by a depletion of muscle free glutamine [3] . Glutamine is a key substrate in a wide variety of synthetic and metabolic processes, and has been suggested to become conditionally essential during metabolic stress [4] .
Intravenous supplementation with glutamine has been reported to attenuate the decrease in protein synthesis associated with trauma and to improve whole-body nitrogen economy [5, 6] . Glutamine-supplemented nutrition has been shown to counteract mucosal atrophy, reduce the length of hospital stay and decrease mortality [7] [8] [9] [10] [11] . Patients undergoing bone marrow transplantation or major surgery show improved nitrogen economy and a reduction in infectious complications when extra glutamine is given [5, 8, 12] . Enterally provided glutamine reduces infectious morbidity [13] . However, the mechanisms by which glutamine supplementation improves morbidity and mortality are not fully understood.
The tripeptide glutathione (L-γ-glutamyl-L-cysteinylglycine) is present at high concentrations in most mammalian cells. It has many protective and metabolic functions within the cell ; among the best recognized of these is its role as a scavenger with the ability to counteract oxidative injury caused by oxygen-derived free radicals and peroxides. It is quantitatively the most important endogenous scavenger system [14] . By reducing peroxides, glutathione protects cell membranes. In addition, glutathione maintains the thiol groups of many proteins in the reduced form, which is required for their normal function. The activity of several enzymes is determined by the ratio of thiols\disulphides, which is modulated mainly by glutathione [15] . The redox status of the cell is therefore related to the glutathione status, which also may influence protein homoeostasis [16] .
After surgical trauma, glutathione concentrations decrease in skeletal muscle [17] , which might indicate ongoing oxidative stress with potential tissue injury [18] . Since the redox status of glutathione seems to be related to the degree of protein degradation, this may contribute to the protein catabolism associated with trauma [16] . Glutamine depletion may contribute to this scavenger deficiency represented by glutathione, via a decreased supply of glutamate.
The primary aim of the present study was to investigate whether intravenous glutamine supplementation influences glutathione metabolism in human skeletal muscle following trauma. A homogeneous group of subjects undergoing a standardized major surgical procedure without complications was used as a human model of trauma. The subjects were given standardized nutrition and were randomly allocated to receive either glutamine or placebo. Glutathione was analysed in muscle biopsies taken before and 24 and 72 h after surgery.
METHODS

Subjects and study protocol
Metabolically healthy, weight-stable subjects (n l 17), 80 years old, undergoing elective and uncomplicated abdominal surgery due to non-spreading rectal cancer and with an expected uneventful post-operative course, were included. Subjects with a clinical history and signs of diabetes mellitus, dysfunctional thyroid gland or coagulopathy were excluded, as were patients on steroid or anti-thrombotic therapy. None of the subjects were treated with low-molecular-mass heparin before surgery. Some subjects were treated with low-dose acetylsalicylic acid, which was withdrawn 7 days before surgery. Individual characteristics are presented in Table 1 . The study design was prospective, double-blind and placebocontrolled. Subjects were randomly allocated to receive total parenteral nutrition (TPN) that was either supplemented with glutamine (0.56 g : day −" : kg −" ) or conventional (without glutamine). After inclusion of subjects into the study, we used a computer-based algorithm stratifying according to length, weight, age, gender, S-albumin, haemoglobin and surgical procedure for randomization. The randomization was not known until all parameters were analysed. Out of the randomized subjects (n l 18), one did not fulfil the inclusion criteria and therefore was excluded (see below).
TPN was given as a continuous infusion during 72 h post-operatively, and was started as soon as the subject entered the recovery room. Energy need was calculated according to the Harris-Benedict equation. TPN was isocaloric and isonitrogenous. Total nitrogen support was 0.22 g : day −" : kg −" in both groups. In the glutamine-supplemented group, amino acid support was given as Glavamine2 (Fresenius Kabi, Uppsala, Sweden) plus an additional aqueous solution of crystalline glutamine. The glutamine in Glavamine was present as a dipeptide (L-glycyl-L-glutamine). The concentration of glutamine in the additional solution was 36 g\litre, prepared from glutamine crystalline powder (Ajinomoto Co., Tokyo, Japan) dissolved in Ringer Acetate2 (Fresenius Kabi). The glutamine powder was controlled for exact glutamine content, and confirmed to be sterile and pyrogen-free. The glutamine solution was prepared in the local pharmacy using sterile filtration. The control group was given Vamin 182 (Fresenius Kabi) ; in this group, all other amino acids were given in larger amounts so that the total supply of nitrogen was the same as in the glutaminesupplemented group. In the glutamine-supplemented group, the provision of essential amino acids was enough to meet daily needs. Non-protein energy was provided as 50 % (w\v) glucose and 50 % (w\v) fat (20 % Intralipid2 ; Fresenius Kabi). Intravenous support was prepared by the pharmacy in equal volumes. Any possible difference in volume between the two groups was corrected by adjusting the glucose concentration. No enteral feeding was allowed during the study period, except for water and tea without sugar or milk.
Giving parenteral nutrition to this group of patients is not routine in clinical practice. However, standard parenteral feeding was used as a model to ensure that nutrition was isonitrogenous and isocaloric. As expected, no complications were seen in terms of hyperglycaemia or thrombosis, as previous experience has shown the safety of giving glutamine-supplemented TPN soon after major abdominal surgery.
The surgical procedure was either an anterior resection or a rectal amputation. Pre-operatively, the patients received radiotherapy for 1 week before the operation, according to clinical routine. The operation took place 1 day after admission to hospital. All subjects were operated on under general anaesthesia, and in addition had an epidural blockade with bupivacain (approx. 0.3 mg : h −" : kg −" ) during the operation. Anaesthesia was induced with 4 mg\kg thiopentothal and 1-2 µg\kg Glutamine supplementation and muscle glutathione fentanyl, and tracheal intubation was facilitated by 0.1 mg\kg atracurium. Anaesthesia was maintained by an inhalation agent (either isoflurane or sevoflurane), with a minimum alveolar concentration of approx. 1.3. Additional fentanyl was not required, because of the analgesic effect of the epidural blockade. Hence the epidural blockade was initiated and well established before the surgical procedure, and was continued for 72 h post-operatively ; the post-operative dose of bupivacain was 0.2-0.3 mg : h −" : kg −" . Post-operative analgesia also included paracetamol (1 gi4 daily), either as Alvedon2 (Astra, So$ derta$ lje, Sweden) rectally or as Prodaphalgan2 (Bristol-Myers Squibb, New York, NY, U.S.A.) intravenously. The visual analogical scale was used to evaluate analgesic treatment, and was kept below 4. If the epidural analgesia did not suffice, morphine was given. One subject in the control group was excluded because of bleeding complications due to splenic laceration with circulatory instability during the surgical procedure, requiring inotropic support. This patient had a prolonged stay in the Intensive Care Unit (ICU). We considered that this was not uncomplicated surgery, and the patient was therefore excluded. Since this occurred before nutritional intervention, complication related to parenteral nutrition was unlikely. Muscle biopsies were taken before surgery, immediately after induction of anaesthesia, and at 24 and 72 h after surgery. Blood samples for the determination of amino acids were also taken at each biopsy occasion, and additionally at 48 h post-operatively.
The study was performed at two hospitals : St Go$ rans Hospital (Stockholm, Sweden) and Ka$ rnsjukhuset (Sko$ vde, Sweden). Patients were distributed equally between the two hospitals, and clinical routines, including surgery, were the same. The purpose, procedure and possible risks involved in the study were explained to the subjects before their voluntary consent was obtained. The study protocol was approved by the Ethics Committee of the Karolinska Institute, Stockholm, Sweden.
Muscle biopsies and blood sampling
Percutaneous muscle biopsies were taken from the vastus lateralis muscle. The skin and fascia were anaesthetized by local anaesthesia with lidocain (1 % solution). The biopsies on the second and third occasions were taken at least 4 cm distant from the previous ones. Both legs were used. The muscle tissue specimen was carefully dissected to remove all visible fat and connective tissue, and thereafter divided into separate portions to allow for the determination of free amino acids (20-30 mg wet weight) and glutathione (30-40 mg wet weight). The separate portions were weighed on an automatic electro balance within 3 min. Biopsy specimens were then frozen immediately in liquid nitrogen and stored at k80 mC, pending analysis. In parallel, venous blood samples were taken for determination of amino acid concentrations in plasma.
Sample preparation
Frozen biopsy specimens were homogenized using a mini-beat beater (Biospec Products, Bartlesville, OK, U.S.A.) in 6.5 % sulphosalicylic acid solution, containing norvaline as an internal standard for amino acid analysis. Samples were subsequently centrifuged at 3000 g for 15 min at 4 mC. The supernatant was used for analyses of amino acids and glutathione.
The method for determining concentrations of glutathione in skeletal muscle has been described in detail elsewhere [19] . The pH of the supernatant was adjusted with excess sodium bicarbonate powder, and part of the sample was derivatized directly for measurement of reduced glutathione and cysteine. Total glutathione and total cysteine were measured after reduction with dithiothreitol. Briefly, a 100 µl portion of neutralized muscle supernatant was treated with 10 µl of 50 mmol\l dithiothreitol, mixed and allowed to stand at room temperature for 30 min. Samples and standard were derivatized using monobromobimane (Calbiochem, La Jolla, CA, U.S.A.) in sodium N-ethylmorpholine.
Aliquots of the derivatized samples were filtered using a 0.22 µm filter and applied to the HPLC column for the determination of thiol bimane adducts. HPLC of glutathione and cysteine was carried out on a column (4.5 mmi150 mm) packed with 3 µm octadecyl-silica reversed resin (Supelco Inc., Bellefonte, PA, U.S.A.) followed by fluorescent detection at excitation 394 nm and emission 480 nm (Millipore Co., Milford, MA, U.S.A.).
The concentration of the oxidized form of glutathione (GSSG) was calculated as : [(total glutathione)k(reduced glutathione)]\2. The redox status of glutathione in muscle is expressed as the ratio between reduced and total glutathione.
Free amino acids in muscle and plasma were analysed as described previously [20] . The pH of the sulphosalicylic acid supernatant was adjusted to 2.2 using 3 mmol\l LiOH. The analysis was performed by automated on-line HPLC after precolumn derivatization using o-phthaldialdehyde\3-mercaptopropionic acid. The amino acids were separated on a Ymc-pack ODS-AQ (150 mmi4.6 mm) column. Fluorimetric detection of amino acids was performed with a Waters 474 fluorescence detector.
Statistical analysis
Glutathione and amino acid concentrations in muscle and in plasma are expressed as meanspS.D. Changes in the concentrations of glutathione and amino acids in muscle and plasma after surgery were assessed by ANOVA followed by Scheffe! s F test. From earlier studies, it is known that levels of both total and reduced glutathione decrease by approx. 40p15 % following abdominal surgery [17] . Our hypothesis was that it would be possible to attenuate this decrease to 20 % by giving glutamine supplementation. A statistical power analysis indicated that a study population of 18 patients would be sufficient to detect this.
RESULTS
Muscle glutathione concentrations
Muscle concentrations of reduced glutathione and total glutathione were analysed in specimens taken prior to Table 2 . ww, wet weight. Significantly different levels compared with basal values are indicated by *P 0.05, **P 0.01, ***P 0.001. Glutamine supplementation and muscle glutathione Table 2 , and individual values for total glutathione are shown in Figure 1 . In the control group, total glutathione had decreased by 47.4p7.9 % and 37.4p11.0 % respectively at 24 and 72 h post-operatively compared with pre-operative values (P 0.05). For reduced glutathione at 24 and 72 h post-operatively, the decreases were 52.7p9.6 % and 45.0p16.4 % respectively (P 0.05) as compared with the basal values seen before surgery (Table 2 ). In contrast, in the glutaminesupplemented group, no significant changes were seen in levels of either total or reduced glutathione ( Table 2 ). The redox status of glutathione in muscle, expressed as the ratio between reduced and total glutathione, did not change sufficiently to reach statistical significance at any time point in either of the groups (Table 2 ).
Muscle and plasma amino acid concentrations
Muscle and plasma amino acid concentrations are given in Tables 3(a) and 3(b) respectively. Glutamine concentrations in skeletal muscle had decreased by 72 h post-operatively in both groups : in the glutamine- (Table 3a) . There were no significant differences between the groups. The plasma concentration of glutamine was higher at both 24 and 72 h post-operatively in the glutamine-supplemented group than in the control group (Figure 2) . The methionine concentration in plasma, but not that in muscle, had increased in the control group at 24 and 72 h postoperatively as compared with the pre-operative value. For the other amino acids, no statistically significant changes were seen.
DISCUSSION
The results of the present study suggest that glutamine supplementation attenuates the trauma-induced decreases in both total and reduced glutathione in skeletal muscle. In the glutamine-supplemented group, there was no significant decrease in either total or reduced glutathione at 24 and 72 h post-operatively as compared with the basal pre-operative values. In contrast, the control group showed a pronounced decrease. Earlier animal studies have demonstrated that glutamine supplementation preserves liver glutathione levels after severe hepatic injury and following chemotherapy [21, 22] . The results from the present study highlight the possibility of restoring muscle glutathione status in humans also. A possible explanation for the attenuated decrease in glutathione concentration in muscle seen in the glutamine-supplemented group is the supply of extra glutamate via glutamine. Muscle glutamine and glutamate Subjects (n l 17) undergoing major abdominal surgery were randomized to receive glutamine ($) or placebo (#). Note that n l 15 at 72 h because two of the patients did not wish to have another muscle biopsy taken. A correlation (r l 0.53, P 0.002) is shown.
concentrations decrease following trauma, while those of the other constituent amino acids of glutathione, i.e. glycine and cysteine, are maintained at normal levels. The extra glutamate ensures sufficient availability of substrate for the γ-glutamylcysteine synthetase reaction, which is the first and rate-limiting step in glutathione synthesis [15] . In addition, feedback inhibition by glutathione upon the activity of γ-glutamylcysteine synthetase can be prevented by glutamate by blockade of the regulatory site on the enzyme [23] . Since glutamate is neurotoxic at high levels, glutamine supplementation seems to be a safe way to supply extra glutamate for glutathione synthesis.
However, in the present study, the effect upon glutathione levels occurred independently of any significant change in muscle free glutamine or glutamate. In the individual subjects, however, the change in glutathione concentration was found to correlate with the change in muscle glutamine (Figure 3) , both for reduced glutathione (r l 0.53, P 0.002) and for total glutathione (r l 0.41, P 0.02). Similar statistical correlations were observed between the change in glutamate concentration and the changes in reduced glutathione (r l 0.38, P 0.05) and total glutathione (r l 0.41, P 0.02). The lack of changes in glutamine and glutamate levels while glutathione depletion was attenuated could possible be explained by increased flux through the glutamine and glutamate pools that did not influence their pool sizes. This explanation implies that attenuation of glutathione is preferred over restoration of the free glutamine pool in skeletal muscle. This is also seen in critically ill patients treated in the ICU, in whom skeletal muscle glutathione levels are restored within the first 1 week of ICU treatment, in contrast with glutamine concentrations, which remain depressed in the absence of glutamine supplementation [24] .
The beneficial effects of glutamine on morbidity and mortality reported in clinical studies [8] [9] [10] [11] might be attributed to the effect of glutamine supplementation on glutathione status. Glutathione is a key scavenger system, which protects against oxidative stress. Ongoing oxidative stress is increased in critical illness, but also after major surgery [17, 25] . In these conditions, reactive oxygen species are produced at increased rates, due mainly to activated neutrophils and granulocytes [26, 27] . Another source of production of reactive oxygen species is reperfusion following ischaemia. Endogenous scavenger systems may be overwhelmed by reactive oxidant species, which may lead to organ failure, since lungs, kidneys, liver and the gastrointestinal tract are all vulnerable to reactive oxidant species [18, [28] [29] [30] . Several studies have suggested that reactive oxidant species play an important role in the pathogenesis of a variety of diseases, e.g. acute respiratory distress syndrome [31] , inflammatory bowel disease [32] , stress-induced gastric mucosal injury [33] and hepatic failure in septic patients [34] . In the present study, the expected decrease in glutathione was prevented in the glutamine-supplemented group. An improved scavenging capacity due to the increased glutathione concentrations may partly explain the shorter hospital stays seen in studies in which glutamine supplementation was given in a double-blind fashion to post-surgical patients [8, 9] . The oxidized state in a tissue is related to protein degradation [16] , which may have an impact on nitrogen economy. Interestingly, a significantly less oxidized state was seen in muscle in the glutamine-supplemented group compared with the unsupplemented controls at 72 h (t test) (Figure 4) .
The use of major abdominal bowel surgery for a metabolic model study was not without problems. The scatter among patients, as well as for the surgical procedure, was greater than for other surgical procedures used in metabolic studies. The strict protocol concerning nutritional supply necessitated TPN or a combination of enteral and parenteral administration. Our protocol used parenteral nutrition only, although this is not the clinical routine for this category of patient at our hospitals. The assumption of the hypothesis was roughly met by the results, since the decrease in glutathione was attenuated by half in the treatment group. This also reached statistical significance if the differences between the preoperative values and those at 24 or 72 h of the two groups were compared using Student's t test (P l 0.013 and P l 0.047 respectively).
Glutamine supplementation was able to normalize the plasma glutamine concentration in the treatment group in the present study. This indicates that the amount provided was sufficient in this respect. The muscle free glutamine concentration is less prone to be influenced by exogenous glutamine supply during severe metabolic Subjects (n l 17) undergoing major abdominal surgery were randomized to receive glutamine ($) or placebo (#). Note that n l 15 at 72 h because two of the patients did not wish to have another muscle biopsy taken. Significant differences between groups are seen, showing a less oxidized state in the glutamine-supplemented group at 72 h (P 0.05).
stress, even when normalized plasma concentrations are obtained. This has been shown in ICU patients [35] and in the present study following a standardized major surgical trauma. After moderate surgical trauma, the plasma glutamine concentration is less prone to be affected, whereas muscle glutamine concentrations decrease [36] . In this situation, exogenous glutamine supplementation attenuates or even maintains the muscle free glutamine concentration [36] . However, when the exogenous extra supply is discontinued, muscle glutamine falls [5, 36] . Restoration of muscle glutamine concentrations back to normal is a slow process, taking 2-4 weeks [6] .
In conclusion, the present study demonstrates that post-traumatic glutathione depletion can be attenuated by glutamine supplementation, which might decrease the susceptibility of the tissues to oxidative damage. The effect on glutathione concentration was related to the changes in glutamine and glutamate status in muscle for the individual subjects. The plasma glutamine concentration was maintained at the basal level in the glutaminetreated group, but depletion of muscle glutamine was not prevented. These effects on glutathione levels may explain the beneficial effects seen on protein metabolism, infectious complications and outcome in conjunction with glutamine supplementation given to patients postoperatively. 
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